NR2E3 (nuclear receptor subfamily 2, group E, member 3), also known as photoreceptor cell-specific nuclear receptor (PNR), is a protein that in humans is encoded by the NR2E3 gene. PNR is a member of the nuclear receptor super family of intracellular transcription factors.
Function NR2E3 was initially cloned from human retinoblastoma Y79 cells and a mouse λZAP eye cDNA library in 1999. In addition to retinal photoreceptor cells, NR2E3 is expressed in many tissues such as the urogenital and respiratory systems in humans and mice, suggesting potential functions beyond the retina cells. The main target genes of PNR as a transcription factor are rhodopsin and several opsins which are essential for sight. Since 2011, NR2E3 has been implicated in tumorigenesis through activating p53 as a transcriptional cofactor. NR2E3 enhances p53 acetylation via forming a complex of NR2E3-p300-p53. NR2E3 mutants such as R76W and R97H, fail to activate p53. Interstingly, NR2E3 rescues the wild-type activity of many mutated p53, including R175H hot-spot gain-of-function mutation. Compound 11a, the agonist of NR2E3, has shown broad inhibitory effects on the cancer cells in NCI-60 cancer cell panel. 11a stimulates NR2E3-mediated p53 activation while also activating NR2E1 and NR2F2 in a less degree. The NR2E3-knock out mouse model suggests that NR2E3 may inhibit liver cancer growth.
Structure and ligands The crystal structure of PNR's ligand-binding domain is known. It self-dimerizes into, by default, a repressor state. Computer simulations based on this model shows that a ligand could possibly fit into PNR and switch it into a transcription activator. 13-cis retinoic acid is a known weak agonist that fits into such a pocket, but no physiologic ligand is known. Two synthetic compounds, 11A and 11B, appear to be agonists but do not go into the pocket and instead work as allosteric modulators. A more recent screening identifies another compound called photoregulin-1 (PR1) that functions as a reverse agonist, an activity possibly useful in the management of retinitis pigmentosa.
Clinical significance Mutations in the NR2E3 gene have been linked to several inherited retinal diseases, including enhanced S-cone syndrome (ESCS), a form of retinitis pigmentosa, and Goldmann-Favre syndrome. By analyzing TCGA database and "All of Us" database, high expression of NR2E3 is associated with superior prognosis of cancer including breast cancer. The mutation frequency of NR2E3 is higher in four types of cancer, such as colon cancer, than in the regular population.
References
Further reading
External links NR2E3+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH) NR2E3 human gene location in the UCSC Genome Browser. NR2E3 human gene details in the UCSC Genome Browser. Overview of all the structural information available in the PDB for UniProt: Q9Y5X4 (Photoreceptor-specific nuclear receptor) at the PDBe-KB.






